Related by context. Frequent words. (Click for all words.) 57 CR# vcMMAE 57 tanespimycin 55 BrachySil 55 romidepsin 55 ponatinib 54 deforolimus 54 Diamyd ® 54 Pirfenidone 54 TNF blocking 54 OXi# 54 Carfilzomib 54 talactoferrin 53 MOZOBIL 53 hematologic cancers 53 RGB # 53 hematological cancers 53 PXD# 53 CA4P 53 Orphan Drug status 52 calcineurin inhibitors 52 NEUMUNE 52 squalamine 52 heavily pretreated 52 BNC# 52 KNS # 51 brostallicin 51 iclaprim 51 CYT# 51 European Medicines Evaluation 51 TELCYTA 50 Satraplatin 50 axitinib 50 AVN# [001] 50 pazopanib 50 Azixa 49 maribavir 49 AZX# 49 phase IIa 49 ProLindac 49 multiple sclerosis rheumatoid arthritis 49 IND submission 49 Phenoptin 49 therapeutic regimens 48 hematologic malignancies 48 Cotara 48 LymphoStat B 48 Serdaxin 48 tamibarotene 48 ICA # 48 phase 2a 48 immunological disorders 47 Desmoteplase 47 registrational 47 IIa clinical trial 47 Rhucin ® 47 Nimotuzumab 47 Synavive 47 zileuton 47 ZADAXIN 47 ocrelizumab 47 HIV associated lipodystrophy 47 Phase 2a trial 47 oncology indications 47 tezampanel 46 placebo controlled clinical trials 46 valopicitabine 46 ELND# 46 Phase IIa trial 46 PLX cells 46 6R BH4 46 fibrotic diseases 45 RRMS patients 45 ASA# 45 BEMA Buprenorphine 45 rhC1INH 45 Folotyn 45 Phase IIa clinical trials 45 efficacy endpoints 45 Asentar 45 GVAX 45 Bapineuzumab 45 dose cohorts 45 outlicensing 44 preclinical models 44 Phase 2a 44 secondary efficacy endpoints 44 pharmacodynamic 44 Phenserine 44 Saphris 44 pharmacokinetic studies 43 Phase Ib 43 riluzole 43 ozarelix 43 subgroup analyzes 43 dose limiting toxicities 43 synthesising 42 bifeprunox 42 midstage study 42 preclinical studies 42 Phase 2b trial 42 T DM1